[ Back to EurekAlert! ]

Contact: Joseph Caputo
joseph_caputo@harvard.edu
617-496-1491
Harvard University

Modified RNA Transfection Corrects Barth Syndrome Dysfunction

Caption: Researchers use modified RNA transfection to correct genetic dysfunction in heart stem cells derived from Barth syndrome patients. The series of images show how inserting modified RNA into diseased cells causes the cells to produce functioning versions of the TAZ protein (first image: in green) that correctly localize in the mitochondria (second image: in red). When the images are merged to demonstrate this localization, green overlaps with red, giving the third image a yellow color.

Credit: Gang Wang and William Pu/Boston Children's Hospital

Usage Restrictions: The image may be used with appropriate credit.

Related news release: Patient stem cells used to make 'heart disease-on-a-chip'


[ Back to EurekAlert! ]